VOLUME 3 INDEX
VOLUME
3, NUMBER 12 3/3/04
- Japan to Introduce Notification System for Medical
Product Changes
- Phase I Clinical Trials for New Drugs in India:
Proposed Amendment
- Chinese Government Implements New Laws on Genetic
Research
- Singapore Creates Center for Drug Administration
VOLUME
3, NUMBER 11 2/3/04
- Japanese Drug Makers Look Overseas for Cheaper
Clinical Trials
- China to Strictly Enforce GMP for Pharmaceutical
Manufacturers
- Singapore Expects to Pass Law Regulating Human
Stem Cell Research
- Malaysia Formulates New Pharmacy Act to Regulate
Alternative Medicines
VOLUME
3, NUMBER 10 1/6/04
- Marketing Authorization Holders for Medical Products in Japan
- India Ponders New Medical Device Regulatory Body
- International Quality Standards for Traditional Chinese Medicines
- Japanese Drug Makers Invest in Genetics-Based
Drugs
VOLUME
3, NUMBER 9 12/2/03
- Three-Year Plan for Promotion of Clinical Trials Unveiled in Japan
- Health Agencies in Singapore and China Form
Strategic Alliance for Cooperation
- ASEAN Plans to Reduce Non-Tariff Barriers for
Cosmetics and Pharmaceuticals
- Unregulated Stents in India Poses Threat to Consumers
VOLUME
3, NUMBER 8 11/4/03
- Japanese PAL Revision: Biological Products
- New Electronic Licensing System in Singapore
- Manufacturing Site Changes in Malaysia
- WTO Leaves Door Open for Generic Drug Manufacturing of Patented
Pharmaceuticals in India
VOLUME
3, NUMBER 7 10/2/03
- Hong Kong Takes Steps towards Legislated Medical
Device Regulations
- Malaysia Launches Online Pharmaceutical Product
Registration System
- Lack of Intellectual Property Protection in South Korea Raises
Concerns
- Cooperation for Mutual New Drugs Recognition between Singapore and
Australia
VOLUME
3, NUMBER 6 9/2/03
- Japanese Government Moving Towards Patents for Medical Procedures
- Increased Regulations on Health Supplements in Singapore
- Individuals Allowed to Invest in Pharmaceutical Sector in Guangdong, China
- Rising Drug Prices Prompts Vietnam's Ministry of Health
to Take Notice
VOLUME
3, NUMBER 5 8/1/03
- Opportunities in China for Foreign Medical Companies As
a Result of SARS
- Revision in Japanese PAL: Measures for Safety Related to
Medical Devices
- Korean Government Taking Steps to Strengthen Pharmaceutical
Industry
- Food Scares in Japan: Government Steps Up Regulations on
Food Safety
VOLUME
3, NUMBER 4 7/2/03
- SARS Scare Toughens Regulatory Procedures for Diagnostic Products
for Infectious Disease in China
- Third-party Certification for Low-Risk Medical Devices in Japan
- China's Pharmaceutical Price Controls Threatens Profit Margins
of Foreign Drug Makers
- Electronic Submissions for Medical Devices in Asia
VOLUME
3, NUMBER 3 6/3/03
- Lifting of Price Controls on Drugs Threatens Smaller Pharmaceutical
Manufacturers in China
- Japanese Pharmaceutical Affairs Law (PAL) Revisions: Labeling
Requirements for Medical Devices
- US Government to Step Up Efforts to Protect Multinational Pharmaceutical
Companies in South Korea
- New Labeling Requirements for Pharmaceuticals in Taiwan
VOLUME
3, NUMBER 2 5/2/03
- Chinese Government Responds to Price Fluctuations of Medical
Products Due to SARS Outbreak
- Medical Device Registration in Japan: Me-too or Partial
Amendment?
- New Medical Device Act in Thailand Expected by 2007
- National Health Insurance Bureau Cuts Subsidies for Prescription
Drugs in Taiwan
VOLUME
3, NUMBER 1 4/2/03
- Japan Signs Bill to Create a New Comprehensive Medical Regulatory
Institution
- India: Double Standard for Counterfeit Drugs
- New Food and Drug Administration to Replace China's State
Drug Administration
- Innovative Treatments for Cardiovascular Disease in Asia
Vol. 8 | Vol. 7 | Vol.6 | Vol.5 | Vol.4 |
Vol.3 | Vol. 2 | Vol.
1
Back to Top
